Author

Wolf‐Rüdiger Ulrich

Observed names: W R Ulrich, W-R Ulrich, W. R. Ulrich, W.-R. Ulrich, W.R. Ulrich, Wolf-Rüdiger Ulrich

Observed institutions: State University of New York, University of Konstanz, Johannes Gutenberg University Mainz, Altana (Germany), Christiani, University Children's Hospital Tübingen, Stony Brook University, University of Tübingen, Ludwig-Maximilians-Universität München

OpenAlex ID: A5111964166

The Leukotriene LTD4 Receptor Antagonist Mk571 Specifically Modulates MRP Associated Multidrug Resistance

1995 · V. Gekeler, W. Ise, et al. · Biochemical and Biophysical Research Communications · 396

The Inhibitory Potency and Selectivity of Arginine Substrate Site Nitric-Oxide Synthase Inhibitors Is Solely Determined by Their Affinity toward the Different Isoenzymes

2000 · Rainer Boer, Wolf-Rüdiger Ulrich, et al. · Molecular Pharmacology · 156

Inhibition of inducible nitric oxide synthase in respiratory diseases

2009 · Christian Hesslinger, Andreas Strub, et al. · Biochemical Society Transactions · 98

The Novel Imidazopyridine 2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) Is a Highly Selective Inhibitor of the Inducible Nitric-Oxide Synthase

2005 · Andreas Strub, Wolf-Rüdiger Ulrich, et al. · Molecular Pharmacology · 37

Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights

2011 · Ulrich Grädler, Thomas Fuchß, et al. · Bioorganic & Medicinal Chemistry Letters · 35

PDF

Characterization of the Dexniguldipine Binding Site in the Multidrug Resistance-Related Transport Protein P-Glycoprotein by Photoaffinity Labeling and Mass Spectrometry

2002 · Christoph Borchers, Rainer Boer, et al. · Molecular Pharmacology · 33

Reversible Labeling of a Chemosensitizer Binding Domain of p-Glycoprotein with a Novel 1,4-Dihydropyridine Drug Transport Inhibitor,

1996 · R. Boer, M. Dichtl, et al. · Biochemistry · 32

Stereoselective inhibition of thromboxane‐induced coronary vasoconstriction by 1,4‐dihydropyridine calcium channel antagonists

1990 · Manfrid Eltze, Karl H. Sanders, et al. · Chirality · 31

In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic α 1A - vs. α 1B - and α 1D -adrenoceptors

2001 · Manfrid Eltze, Rainer Boer, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 29

Cope-Umlagerungen mit dipolaren Zwischenprodukten

1976 · Rudolf Gompper, Wolf-Rüdiger Ulrich · Angewandte Chemie · 28

Cope Rearrangement with Dipolar Intermediates

1976 · Rudolf Gompper, Wolf‐Rüdiger Ulrich · Angewandte Chemie International Edition in English · 22

Structure and potential C‐terminal dimerization of a recombinant mutant of surfactant‐associated protein C in chloroform/methanol

2004 · Burkhard Luy, Alexander Diener, et al. · European Journal of Biochemistry · 21

B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoprotein.

1995 · C Borchers, W R Ulrich, et al. · Molecular Pharmacology · 20

Interaction of cytostatics and chemosensitizers with the dexniguldipine binding site on P-glycoprotein

1996 · Rainer Boer, Wolf-Rüdiger Ulrich, et al. · European Journal of Pharmacology · 18

Modulation of P-glycoprotein mediated drug accumulation in multidrug resistant CCRF VCR-1000 cells by chemosensitisers

1996 · R. Boer, V. Gekeler, et al. · European Journal of Cancer · 17

Hetero-Cope-Umlagerungen mit dipolaren Zwischenprodukten

1976 · Rudolf Gompper, Wolf-Rüdiger Ulrich · Angewandte Chemie · 17

Hetero Cope Rearrangements with Dipolar Intermediates

1976 · Rudolf Gompper, Wolf‐Rüdiger Ulrich · Angewandte Chemie International Edition in English · 13

In Vivo Characterization of the Novel Imidazopyridine BYK191023 [2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3 H-imidazo[4,5-b]pyridine], a Potent and Highly Selective Inhibitor of Inducible Nitric-Oxide Synthase

2006 · Martin D. Lehner, Degenhard Marx, et al. · Journal of Pharmacology and Experimental Therapeutics · 12

Localization of the 1,4-dihydropyridine drug acceptor of P-glycoprotein to a cytoplasmic domain using a permanently charged derivative N-methyl dexniguldipine

2000 · D. Ferry, R. Boer, et al. · International Journal of Clinical Pharmacology and Therapeutics · 11

Rhodamine 123 efflux modulation in the presence of low or high serum from CD56+ hematopoietic cells or CD34+ leukemic blasts by B9309-068, a newly designed pyridine derivative

1998 · James Friedrich Beck, Frank Buchholz, et al. · Cancer Letters · 4

Photoaffinity labelling with a photoreactive analogue of dexniguldipine-HCl (B8509-035) and mass spectrometric structural characterization of the multidrug resistance-related P-glycoprotein

1995 · C. Borchers, R. Boer, et al. · Springer eBooks · 2

Potent and highly selective inhibition of the inducible nitric oxide synthase by BYK191023

2006 · Christian Hesslinger, Andreas Strub, et al. · GBM Annual Spring meeting Mosbach 2006 · 1

O34. Potent and highly selective inhibition of the inducible nitric oxide synthase in vitro and in vivo by the novel imidazopyridine BYK191023

2006 · Andreas Strub, Christian Hesslinger, et al. · Nitric Oxide

The application of 2-(2-pyridylmethylsulfinyl)benzimidazoles as new thiol reagents

1999 · Volker Figala, Ernst Sturm, et al.

Photo-affinity labeling of P-glycoprotein (P-gp) with a photoreactive analog of dexniguldipine-HCl

1994 · C Borchers, R Boer, et al. · Anti-Cancer Drugs

Works count: 26

Citation count: 1,033

H-index: 16

I10-index: 19